Alembic Pharmaceuticals rises on selling formulations manufacturing facility at Baddi

24 Aug 2017 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 515.75, up by 10.10 points or 2.00% from its previous closing of Rs. 505.65 on the BSE.

The scrip opened at Rs. 516.05 and has touched a high and low of Rs. 519.35 and Rs. 513.80 respectively.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 709.30 on 23-Mar-2017 and a 52 week low of Rs. 492.25 on 27-Jun-2017.

Last one week high and low of the scrip stood at Rs. 525.05 and Rs. 503.30 respectively. The current market cap of the company is Rs. 9,722.00 crore.

The promoters holding in the company stood at 72.68%, while Institutions and Non-Institutions held 14.00% and 13.32% respectively.

Alembic Pharmaceuticals has sold on slump sale basis, its formulations manufacturing facility at Baddi, Himachal Pradesh to Scott Edil Pharmacia (SEPL), a company engaged in the business of pharmaceuticals products.

The turnover and net-worth of the said manufacturing facility for the last financial year compared to the turnover and net-worth of the company is insignificant. The company continues to meet its domestic formulation demand from Sikkim Unit and international formulation demand from its Panelav Unit.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.


Alembic Pharma Share Price

850.65 4.50 (0.53%)
17-Dec-2025 10:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.20
Dr. Reddys Lab 1272.20
Cipla 1496.25
Zydus Lifesciences 918.00
Lupin 2118.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×